80/100B160.420
USD
-2.88
(-1.76%)
Pre Open
Last updated: · Delayed 15 min
Fair value128.72Plus+25%103Price 160.42634
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Novartis total debt 1998–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Novartis's total debt was 48.31B USD on 30 September 2026, up 50.9% on a year before. At the end of fiscal year 2025 it was 35.38B USD.
Last updated 8 Nov 2026 · Next report 3 Feb 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 48.31B | +50.87% | 8.98B | -39.34B | 1.30 |
| FY2025 | 31 Dec 2025 | 35.38B | +13.17% | 11.59B | -23.79B | 0.77 |
| FY2024 | 31 Dec 2024 | 31.26B | +18.64% | 13.35B | -17.91B | 0.71 |
| FY2023 | 31 Dec 2023 | 26.35B | -5.59% | 13.96B | -12.39B | 0.56 |
| FY2022 | 31 Dec 2022 | 27.91B | -10.04% | 18.62B | -9.29B | 0.47 |
| FY2021 | 31 Dec 2021 | 31.03B | -18.04% | 28.11B | -2.91B | 0.46 |
| FY2020 | 31 Dec 2020 | 37.86B | +29.87% | 11.56B | -26.29B | 0.67 |
| FY2019 | 31 Dec 2019 | 29.15B | -9.17% | 11.45B | -17.70B | 0.53 |
| FY2018 | 31 Dec 2018 | 32.09B | +12.89% | 15.96B | -16.13B | 0.41 |
| FY2017 | 31 Dec 2017 | 28.43B | +19.42% | 9.49B | -18.94B | 0.38 |
| FY2016 | 31 Dec 2016 | 23.80B | +8.53% | 7.78B | -16.03B | 0.32 |
| FY2015 | 31 Dec 2015 | 21.93B | +7.45% | 5.45B | -16.48B | 0.28 |
| FY2014 | 31 Dec 2014 | 20.41B | +13.28% | 13.86B | -6.55B | 0.29 |
| FY2013 | 31 Dec 2013 | 18.02B | -8.66% | 9.22B | -8.80B | 0.24 |
| FY2012 | 31 Dec 2012 | 19.73B | -2.34% | 8.12B | -11.61B | 0.29 |
| FY2011 | 31 Dec 2011 | 20.20B | -11.96% | 5.08B | -15.12B | 0.31 |
| FY2010 | 31 Dec 2010 | 22.94B | +64.96% | 8.13B | -14.81B | 0.36 |
| FY2009 | 31 Dec 2009 | 13.91B | +97.70% | 17.45B | 3.54B | 0.24 |
| FY2008 | 31 Dec 2008 | 7.04B | +25.78% | 6.12B | -918.00M | 0.14 |
| FY2007 | 31 Dec 2007 | 5.59B | -22.49% | 13.20B | 7.61B | 0.11 |
| FY2006 | 31 Dec 2006 | 7.22B | -12.10% | 7.96B | 739.00M | 0.18 |
| FY2005 | 31 Dec 2005 | 8.21B | +25.18% | 10.93B | 2.72B | 0.25 |
| FY2004 | 31 Dec 2004 | 6.56B | +19.87% | 14.59B | 8.04B | 0.19 |
| FY2003 | 31 Dec 2003 | 5.47B | -2.04% | 13.26B | 7.79B | 0.18 |
| FY2002 | 31 Dec 2002 | 5.59B | +22.32% | 12.58B | 6.99B | 0.20 |
| FY2001 | 31 Dec 2001 | 4.57B | +23.54% | 13.18B | 8.62B | 0.18 |
| FY2000 | 31 Dec 2000 | 3.70B | -40.78% | 12.51B | 8.82B | 0.16 |
| FY1999 | 31 Dec 1999 | 6.24B | +0.09% | 10.27B | 4.03B | 0.27 |
| FY1998 | 31 Dec 1998 | 6.24B | — | 9.69B | 3.46B | 0.28 |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 48.31B | +50.87% | 8.98B | -39.34B | 1.30 |
| Q2 FY2026 | 30 Jun 2026 | 49.01B | +50.18% | 7.69B | -41.32B | 1.18 |
| Q1 FY2026 | 31 Mar 2026 | 47.00B | +50.30% | 6.98B | -40.02B | 1.22 |
| Q4 FY2025 | 31 Dec 2025 | 37.11B | +18.73% | 11.59B | -25.52B | 0.80 |
| Q3 FY2025 | 29 Sept 2025 | 32.02B | -0.43% | 9.75B | -22.27B | 0.72 |
| Q2 FY2025 | 30 Jun 2025 | 32.64B | +12.59% | 7.00B | -25.64B | 0.78 |
| Q1 FY2025 | 31 Mar 2025 | 31.27B | +14.61% | 7.20B | -24.07B | 0.81 |
| Q4 FY2024 | 31 Dec 2024 | 31.26B | +18.64% | 13.35B | -17.91B | 0.71 |
| Q3 FY2024 | 30 Sept 2024 | 32.16B | +27.67% | 14.02B | -18.14B | 0.74 |
| Q2 FY2024 | 30 Jun 2024 | 28.99B | +2.28% | 8.44B | -20.55B | 0.69 |
| Q1 FY2024 | 31 Mar 2024 | 27.28B | -6.57% | 9.69B | -17.59B | 0.69 |
| Q4 FY2023 | 31 Dec 2023 | 26.35B | -5.59% | 14.43B | -11.92B | 0.56 |
| Q3 FY2023 | 30 Sept 2023 | 25.19B | -11.74% | 12.70B | -12.49B | 0.66 |
| Q2 FY2023 | 30 Jun 2023 | 28.34B | -8.84% | 11.17B | -17.17B | 0.55 |
| Q1 FY2023 | 31 Mar 2023 | 29.20B | -6.82% | 12.26B | -16.94B | 0.56 |
| Q4 FY2022 | 31 Dec 2022 | 27.91B | -10.04% | 18.93B | -8.98B | 0.47 |
| Q3 FY2022 | 30 Sept 2022 | 28.54B | -16.87% | 19.10B | -9.44B | 0.47 |
| Q2 FY2022 | 30 Jun 2022 | 31.09B | -13.27% | 19.76B | -11.33B | 0.49 |
| Q1 FY2022 | 31 Mar 2022 | 31.34B | -17.18% | 18.81B | -12.53B | 0.51 |
| Q4 FY2021 | 31 Dec 2021 | 31.03B | -18.04% | 28.33B | -2.70B | 0.46 |
| Q3 FY2021 | 30 Sept 2021 | 34.33B | -10.07% | 8.16B | -26.17B | 0.60 |
| Q2 FY2021 | 30 Jun 2021 | 35.85B | +3.04% | 5.36B | -30.49B | 0.66 |
| Q1 FY2021 | 31 Mar 2021 | 37.84B | +3.13% | 4.08B | -33.77B | 0.75 |
| Q4 FY2020 | 31 Dec 2020 | 37.86B | +29.87% | 11.56B | -26.29B | 0.67 |
| Q3 FY2020 | 30 Sept 2020 | 38.18B | +26.76% | 10.87B | -27.31B | 0.70 |
| Q2 FY2020 | 30 Jun 2020 | 34.79B | +14.93% | 6.29B | -28.49B | 0.65 |
| Q1 FY2020 | 31 Mar 2020 | 36.70B | +19.96% | 4.97B | -31.72B | 0.72 |
| Q4 FY2019 | 31 Dec 2019 | 29.15B | -9.17% | 11.45B | -17.70B | 0.53 |
| Q3 FY2019 | 30 Sept 2019 | 30.12B | -5.24% | 8.72B | -21.40B | 0.57 |
| Q2 FY2019 | 30 Jun 2019 | 30.27B | -6.46% | 10.34B | -19.93B | 0.59 |
| Q1 FY2019 | 31 Mar 2019 | 30.59B | -10.32% | 7.11B | -23.48B | 0.65 |
| Q4 FY2018 | 31 Dec 2018 | 32.09B | +12.89% | 15.96B | -16.13B | 0.41 |
| Q3 FY2018 | 30 Sept 2018 | 31.78B | +5.38% | 14.71B | -17.07B | 0.41 |
| Q2 FY2018 | 30 Jun 2018 | 32.36B | +5.87% | 13.15B | -19.21B | 0.42 |
| Q1 FY2018 | 31 Mar 2018 | 34.11B | +9.13% | 6.42B | -27.69B | 0.48 |
| Q4 FY2017 | 31 Dec 2017 | 28.43B | +19.42% | 9.49B | -18.94B | 0.38 |
| Q3 FY2017 | 30 Sept 2017 | 30.16B | +13.53% | 9.40B | -20.76B | 0.42 |
| Q2 FY2017 | 30 Jun 2017 | 30.56B | +15.90% | 8.42B | -22.14B | 0.44 |
| Q1 FY2017 | 31 Mar 2017 | 31.26B | +11.26% | 8.24B | -23.02B | 0.46 |
| Q4 FY2016 | 31 Dec 2016 | 23.80B | +8.53% | 7.78B | -16.03B | 0.32 |
| Q3 FY2016 | 30 Sept 2016 | 26.57B | +17.03% | 7.74B | -18.83B | 0.35 |
| Q2 FY2016 | 30 Jun 2016 | 26.37B | +13.29% | 5.65B | -20.72B | 0.36 |
| Q1 FY2016 | 31 Mar 2016 | 28.09B | +11.87% | 5.07B | -23.02B | 0.39 |
| Q4 FY2015 | 31 Dec 2015 | 21.93B | +7.45% | 5.45B | -16.48B | 0.28 |
| Q3 FY2015 | 30 Sept 2015 | 22.70B | +15.78% | 5.93B | -16.77B | 0.30 |
| Q2 FY2015 | 30 Jun 2015 | 23.27B | +13.92% | 5.81B | -17.46B | 0.30 |
| Q1 FY2015 | 31 Mar 2015 | 25.11B | +18.40% | 7.36B | -17.75B | 0.33 |
| Q4 FY2014 | 31 Dec 2014 | 20.41B | +13.28% | 13.86B | -6.55B | 0.29 |
| Q3 FY2014 | 30 Sept 2014 | 19.61B | +4.43% | 10.43B | -9.18B | 0.27 |
| Q2 FY2014 | 30 Jun 2014 | 20.43B | +8.26% | 7.32B | -13.11B | 0.29 |
| Q1 FY2014 | 31 Mar 2014 | 21.21B | +1.27% | 7.72B | -13.49B | 0.30 |
| Q4 FY2013 | 31 Dec 2013 | 18.02B | -8.66% | 9.22B | -8.80B | 0.24 |
| Q3 FY2013 | 30 Sept 2013 | 18.78B | -9.91% | 7.27B | -11.51B | 0.26 |
| Q2 FY2013 | 30 Jun 2013 | 18.87B | -16.62% | 5.09B | -13.78B | 0.27 |
| Q1 FY2013 | 31 Mar 2013 | 20.94B | -14.84% | 6.04B | -14.91B | 0.31 |
| Q4 FY2012 | 31 Dec 2012 | 19.73B | -2.34% | 8.12B | -11.61B | 0.29 |
| Q3 FY2012 | 30 Sept 2012 | 20.84B | -12.77% | 0.00 | -20.84B | 0.31 |
| Q2 FY2012 | 30 Jun 2012 | 22.63B | -17.72% | 0.00 | -22.63B | 0.35 |
| Q1 FY2012 | 31 Mar 2012 | 24.59B | -20.95% | 0.00 | -24.59B | 0.39 |
| Q4 FY2011 | 31 Dec 2011 | 20.20B | -11.96% | 5.08B | -15.12B | 0.31 |
| Q3 FY2011 | 30 Sept 2011 | 23.89B | -11.39% | 0.00 | -23.89B | 0.36 |
| Q2 FY2011 | 30 Jun 2011 | 27.51B | +47.54% | 0.00 | -27.51B | 0.41 |
| Q1 FY2011 | 31 Mar 2011 | 31.11B | +73.53% | 0.00 | -31.11B | 0.48 |
| Q4 FY2010 | 31 Dec 2010 | 22.94B | +64.96% | 8.13B | -14.81B | 0.36 |
| Q3 FY2010 | 30 Sept 2010 | 26.96B | +87.68% | 0.00 | -26.96B | 0.41 |
| Q2 FY2010 | 30 Jun 2010 | 18.64B | +34.42% | 0.00 | -18.64B | 0.33 |
| Q1 FY2010 | 31 Mar 2010 | 17.93B | +56.56% | 0.00 | -17.93B | 0.32 |
| Q4 FY2009 | 31 Dec 2009 | 13.91B | +97.70% | 17.45B | 3.54B | 0.24 |
| Q3 FY2009 | 30 Sept 2009 | 14.37B | +32.97% | 0.00 | -14.37B | 0.27 |
| Q2 FY2009 | 30 Jun 2009 | 13.87B | +29.24% | 0.00 | -13.87B | 0.27 |
| Q1 FY2009 | 31 Mar 2009 | 11.45B | +76.76% | 0.00 | -11.45B | 0.25 |
| Q4 FY2008 | 31 Dec 2008 | 7.04B | +25.78% | 6.12B | -918.00M | 0.14 |
| Q3 FY2008 | 30 Sept 2008 | 10.80B | +49.16% | 8.14B | -2.67B | 0.21 |
| Q2 FY2008 | 30 Jun 2008 | 10.73B | +44.02% | 16.20B | 5.47B | 0.21 |
| Q1 FY2008 | 31 Mar 2008 | 6.48B | -11.85% | 10.85B | 4.37B | 0.13 |
| Q4 FY2007 | 31 Dec 2007 | 5.59B | -22.49% | 13.20B | 7.61B | 0.11 |
| Q3 FY2007 | 30 Sept 2007 | 7.24B | -21.45% | 14.53B | 7.29B | 0.15 |
| Q2 FY2007 | 30 Jun 2007 | 7.45B | -20.95% | 7.55B | 97.00M | 0.17 |
| Q1 FY2007 | 31 Mar 2007 | 7.35B | -9.19% | 6.96B | -393.00M | 0.18 |
| Q4 FY2006 | 31 Dec 2006 | 7.22B | -12.10% | 7.96B | 739.00M | 0.18 |
| Q3 FY2006 | 30 Sept 2006 | 9.22B | +33.60% | 8.53B | -691.00M | 0.24 |
| Q2 FY2006 | 30 Jun 2006 | 9.43B | +22.51% | 7.31B | -2.12B | 0.25 |
| Q1 FY2006 | 31 Mar 2006 | 8.09B | +33.85% | 11.12B | 3.02B | 0.24 |
| Q4 FY2005 | 31 Dec 2005 | 8.21B | +25.18% | 10.93B | 2.72B | 0.25 |
| Q3 FY2005 | 30 Sept 2005 | 6.90B | +24.79% | 7.95B | 1.05B | 0.22 |
| Q2 FY2005 | 30 Jun 2005 | 7.69B | +28.49% | 9.44B | 1.75B | 0.25 |
| Q1 FY2005 | 31 Mar 2005 | 6.05B | -7.59% | 12.28B | 6.24B | 0.21 |
| Q4 FY2004 | 31 Dec 2004 | 6.56B | +19.87% | 14.59B | 8.04B | 0.19 |
| Q3 FY2004 | 30 Sept 2004 | 5.53B | -1.65% | 12.19B | 6.65B | 0.18 |
| Q2 FY2004 | 30 Jun 2004 | 5.99B | -14.09% | 12.30B | 6.31B | 0.20 |
| Q1 FY2004 | 31 Mar 2004 | 6.54B | +11.31% | 12.11B | 5.56B | 0.22 |
| Q4 FY2003 | 31 Dec 2003 | 5.47B | -2.04% | 13.26B | 7.79B | 0.18 |
| Q3 FY2003 | 30 Sept 2003 | 5.62B | +14.43% | 11.85B | 6.23B | 0.20 |
| Q2 FY2003 | 30 Jun 2003 | 6.97B | +38.05% | 11.14B | 4.17B | 0.26 |
| Q1 FY2003 | 31 Mar 2003 | 5.88B | — | 12.90B | 7.02B | 0.21 |
| Q4 FY2002 | 31 Dec 2002 | 5.59B | +22.32% | 12.58B | 6.99B | 0.20 |
| Q3 FY2002 | 30 Sept 2002 | 4.92B | — | 10.33B | 5.42B | 0.19 |
| Q2 FY2002 | 30 Jun 2002 | 5.05B | +16.71% | 12.91B | 7.86B | 0.18 |
| Q4 FY2001 | 31 Dec 2001 | 4.57B | +23.54% | 13.18B | 8.62B | 0.18 |
| Q2 FY2001 | 30 Jun 2001 | 4.33B | -15.04% | 8.41B | 4.08B | 0.21 |
| Q4 FY2000 | 31 Dec 2000 | 3.70B | — | 12.51B | 8.82B | 0.16 |
| Q2 FY2000 | 30 Jun 2000 | 5.09B | — | 12.94B | 7.85B | 0.22 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet
Common questions about Novartis's debt
Source: Financial Modeling Prep